Physician profile
William E Burch
NPI 1932938453
$1,183.60
in general payments reported to CMS, 2019-2025
13 companies · $1,184 in 2025
The $1,184 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,150 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,149.60 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $277.40 | 2025 | Tezspire, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $176.20 | 2025 | Trelegy Ellipta, Nucala |
| Genzyme Corporation | $149.62 | 2025 | |
| Mallinckrodt Hospital Products INC. | $114.20 | 2025 | Acthar |
| Boehringer Ingelheim Pharmaceuticals, INC. | $92.40 | 2025 | Jascayd, Ofev |
| Verona Pharma, INC. | $81.93 | 2025 | Ohtuvayre |
| Merck Sharp & Dohme LLC | $64.26 | 2025 | Zerbaxa |
| Takeda Pharmaceuticals U.S.A., INC. | $54.55 | 2025 | Glassia |
| Insmed, INC. | $49.22 | 2025 | Arikayce, Brinsupri |
| Amgen INC. | $48.75 | 2025 | Tezspire |
| Regeneron Healthcare Solutions, INC. | $35.82 | 2025 | Dupixent |
| United Therapeutics Corporation | $25.71 | 2025 | Tyvaso |
| Philips North America LLC | $13.54 | 2025 | Vest Therapy Und |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Burch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.